SAS - D.S.A.P. Bahía de Cádiz-La Janda

Permanent URI for this collection

https://hdl.handle.net/10668/22682

Browse

Now showing 1 - 17 of 17

[Magnetic resonance imaging abnormalities associated with vigabatrin therapy].
(2020-12-11) Lubián-Gutiérrez, Manuel; Benavente-Fernández, Isabel; Zuazo-Ojeda, Amaya; Lubián-López, Simón Pedro
[Efficacy of tele-rehabilitation in patients with chronic obstructive pulmonary disease: a systematic review].
(2022-06-30) Vinolo-Gil, M J; Herrera-Sánchez, C; Martin-Vega, F J; Martín-Valero, R; Gonzalez-Medina, G; Pérez-Cabezas, V
The COVID-19 pandemic has required the use of new technologies to carry out rehabilitation sessions for COP D remotely. The aim of this systematic review was to analyse the available evidence on the efficacy of telerehabilitation in COPD patients. PubMed, WOS, PEDro and Cochrane databases were consulted. The systematic review included nine clinical trials, 55.5% of which display good methodological quality. The most commonly used rehabilitation methods were applications or software for real-time video-calls, visualisation of exercises and recording progress. TR was as effective as outpatient pulmonary rehabilitation, with greater benefits in functional capacity, self-efficacy, mental health, exacerbations and emergency care visits, offering a cost-effective option with high patient satisfaction. The small number of studies and the variety of rehabilitation methods examined limit the value of the evidence obtained.
Bereavement Needs Assessment in Nurses: Elaboration and Content Validation of a Professional Traumatic Grief Scale.
(2022-03-03) Gilart, Ester; Lepiani, Isabel; Dueñas, María; Cantizano Nuñez, Maria José; Baena, Belen Gutierrez; Bocchino, Anna
The COVID-19 pandemic has caused a series of biopsychosocial repercussions among nursing professionals. The impossibility of anticipating the events, the numerous deaths, the excessive workload, the lack of personal health and the necessary means of protection made it difficult to regulate the impact and the elaboration of grief to the point of becoming, on many occasions, a traumatic grief whose physical and psychological manifestations are becoming more and more evident. The main objective of this research was to develop a scale for a group of symptoms based on professional traumatic grief. The development consisted of two phases: (I) instrument design through a literature review and focus groups of bereavement experts and healthcare professionals who experience the grief process in their work; and (II) validation of the content of the instrument. A total of 25 final items were established as suitable for inclusion in the instrument. It is expected that the experiences and results obtained through the development and validation of a scale of specific symptomatology of professional traumatic grief in health professionals will allow the assessment and detection of symptomatology in order to develop programs and strategies for early intervention and prevention.
Rapid subcutaneous desensitization for treatment of hypersensitivity reactions to etanercept in two patients with positive basophil activation test
(Japanese society allergology, 2017-04-01) de la Varga Martinez, Raquel; Gutierrez Fernandez, Diego; Foncubierta Fernandez, Antonio; Andres Garcia, Jose Antonio; Medina Varo, Fermin; [de la Varga Martinez, Raquel] Hosp Univ Puerta Mar, Unidad Invest, Area Invest Clin Inmunol & Reumatol, Ave Ana Viya 21, Cadiz 11009, Spain; [Gutierrez Fernandez, Diego] Hosp Univ Puerta Mar, Unidad Alergol, UGC Neumol Alergia, Cadiz, Spain; [Foncubierta Fernandez, Antonio] Dist Sanitario Bahia Cadiz La Janda, UGC Joaquin Pece, Cadiz, Spain; [Andres Garcia, Jose Antonio] Hosp Univ Puerta Mar, Unidad Traumatol, UGC Cirugia Ortoped Traumatol & Reumatol, Cadiz, Spain; [Medina Varo, Fermin] Hosp Univ Puerta Mar, Unidad Reumatol, UGC Cirugia Ortoped Traumatol & Reumatol, Cadiz, Spain
Case Report: Fatigue and Bleeding in a Polymedicated Patient Using Several Herbal Supplementations, Detected with g-Nomic® Software.
(2021-08-12) Saldarreaga Marin, Abel; Cendros, Marc; Ciudad, Carlos J; Sabater, Ana
This was a case report of severe fatigue and bleeding in a 65-year-old man with ischemic heart disease who was wearing a stent and taking multiple medications for hypertension and diabetes. The use of a drug interaction and personalized prescription software (g-Nomic®) revealed potential interactions, involving acetylsalicylic acid and several non-pharmaceutical products including ginger, blueberry extracts, pineapple juice, docosahexaenoic acid and liquorice. Correction of these interactions resulted in complete remission of the reported side effects. This supports the idea that non-pharmaceuticals potentiated the effects of acetylsalicylic acid on haemostasis, producing the bleeding that would have caused fatigue. It is important to use appropriate tools to detect drug interactions that also take into account commonly used non-pharmaceutical products. Drug interactions can be considered illnesses by themselves.
Sleep Characteristics in Diabetic Patients Depending on the Occurrence of Neuropathic Pain and Related Factors.
(2020-11-03) Naranjo, Cristina; Dueñas, María; Barrera, Carlos; Moratalla, Guillermo; Failde, Inmaculada
This study aims to compare the sleep characteristics (structure and quality) in patients with type-2 diabetes mellitus with and without diabetic neuropathic pain (DNP), and to investigate the relationship of sensory phenotypes, anxiety, and depression with sleep quality in DNP patients. A cross-sectional study was performed in patients with type-2 diabetes mellitus and neuropathy. Patients were classified into two groups-with or without neuropathic pain-according to the "Douleur Neuropathique-4 (DN4)" scale. Sleep characteristics and quality (Medical Outcomes Study-MOS-sleep), pain phenotype (Neuropathic Pain Symptom Inventory-NPSI), mood status (Hospital Anxiety and Depression scale-HADS), pain intensity (Visual Analogue Scale-VAS), and quality of life (SF-12v2) were measured. The sample included 130 patients (65 with DNP). The mean scores in all the dimensions of the MOS-sleep scale were higher (more disturbances) in the DNP patients. Higher scores in anxiety or depression, greater intensity of pain or a higher score in the paroxysmal pain phenotype were associated with lower sleep quality in DNP patients. A shorter duration of the diabetes and lower levels of glycated hemoglobin were also associated with lower sleep quality. The results show the relationship between DNP and sleep quality, and the importance of assessing sensory phenotypes and mental comorbidities in these patients. Taking these factors into consideration, to adopt a multimodal approach is necessary to achieve better clinical results.
Effectiveness of a Multifactorial Intervention in the First 1000 Days of Life to Prevent Obesity and Overweight in Childhood: Study Protocol.
(2020-03-26) Díaz-Rodríguez, Mercedes; Pérez-Muñoz, Celia; Lendínez-de la Cruz, José Manuel; Fernández-Gutiérrez, Martina; Bas-Sarmiento, Pilar; Ferriz-Mas, Bernardo C
(1) Background: Obesity is a global health problem, and its prevention must be a priority goal of public health, especially considering the seriousness of the problem among children. It is known that fetal and early postnatal environments may favor the appearance of obesity in later life. In recent years, the impact of the programs to prevent obesity in childhood has been scarce. The aim of this research is to evaluate the effectiveness of an intervention based on the concept of early programming. (2) Methods: Non-randomized controlled trial design. Inclusion criteria are: two-year-old infants whose gestational period begins in the 14 months following the start of the intervention, and whose mothers have made the complete follow-up of their pregnancy in the same clinical unit of the study. The intervention will be developed over all the known factors that affect early programming, during pregnancy up to 2 years of life. Data will be collected through a data collection sheet by the paediatricians. A unibivariate and multivariate analysis of the data will be carried out. (3) Ethics and dissemination: The trial does not involve any risk to participants and their offspring. Signed informed consent is obtained from all participants. Ethical approval has been obtained. (4) Results: It is expected that this study will provide evidence on the importance of the prevention of obesity from the critical period of the first 1000 days of life, being able to establish this as a standard intervention in primary care.
Quantification of inaccurate diagnosis of COPD in primary care medicine: an analysis of the COACH clinical audit.
(2019-06-06) Abad-Arranz, María; Moran-Rodríguez, Ana; Mascarós Balaguer, Enrique; Quintana Velasco, Carmen; Abad Polo, Laura; Núñez Palomo, Sara; Gonzálvez Rey, Jaime; Fernández Vargas, Ana María; Hidalgo Requena, Antonio; Helguera Quevedo, Jose Manuel; García Pardo, Marina; Lopez-Campos, Jose Luis
Background: Inaccurate diagnosis in COPD is a current problem with relevant consequences in terms of inefficient health care, which has not been thoroughly studied in primary care medicine. The aim of the present study was to evaluate the degree of inaccurate diagnosis in Primary Care in Spain and study the determinants associated with it. Methods: The Community Assessment of COPD Health Care (COACH) study is a national, observational, randomized, non-interventional, national clinical audit aimed at evaluating clinical practice for patients with COPD in primary care medicine in Spain. For the present analysis, a correct diagnosis was evaluated based on previous exposure and airway obstruction with and without the presence of symptoms. The association of patient-level and center-level variables with inaccurate diagnosis was studied using multivariate multilevel binomial logistic regression models. Results: During the study 4,307 cases from 63 centers were audited. The rate of inaccurate diagnosis was 82.4% (inter-regional range from 76.8% to 90.2%). Patient-related interventions associated with inaccurate diagnosis were related to active smoking, lung function evaluation, and specific therapeutic interventions. Center-level variables related to the availability of certain complementary tests and different aspects of the resources available were also associated with an inaccurate diagnosis. Conclusions: The prevalence data for the inaccurate diagnosis of COPD in primary care medicine in Spain establishes a point of reference in the clinical management of COPD. The descriptors of the variables associated with this inaccurate diagnosis can be used to identify cases and centers in which inaccurate diagnosis is occurring considerably, thus allowing for improvement.
[Healthcare resources for asthma management at primary care level: Asthmabarometer Project].
(2018-12-24) Molina París, Jesús; Mascarós Balaguer, Enrique; Ocaña Rodríguez, Daniel; Simonet Aineto, Pere; Campo Sien, Carlos
The objective of this study was to describe the current provision of basic resources for asthma management in Primary Health Care (PHC). Cross-sectional study, with an ad hoc quantitative survey. A total of 380 primary healthcare physicians in Spain. Analysis of perceptions of management and use of basic human, organisational and material resources to ensure appropriate care provision to asthma patients. Survey respondents stated that their centre did not have a consultant doctor (64%) or nurse (62%) in respiratory disease. Almost all (92%) of the centres have spirometers, of which 70% have peak flow meters, and 93% have placebo inhalers. In the last year, respondents have received specific theoretical/practical training from the centre (46%), and by third parties (83%). More than three-quarters (78%) of the centres has educational material available for patients. There is no specific healthcare protocol in 36% of the centres, and 43% had no referral protocol. A clinical interview is conducted to monitor the patient (90%), but there are no validated questionnaires to measure therapeutic adherence (85%), or a checklist to check inhalation technique (83%). Differences are observed in the relevant variables in the analysis of each Spanish Autonomous Community. Access to certain resources in the care of patients with asthma is limited in aspects of coordination between levels, varied according to Spanish Autonomous Community, and improved in most health resources in Asthma.
Community Assessment of COPD Health Care (COACH) study: a clinical audit on primary care performance variability in COPD care.
(2018-07-03) Abad-Arranz, María; Moran-Rodríguez, Ana; Mascarós Balaguer, Enrique; Quintana Velasco, Carmen; Abad Polo, Laura; Núñez Palomo, Sara; Gonzálvez Rey, Jaime; Fernández Vargas, Ana María; Hidalgo Requena, Antonio; Helguera Quevedo, Jose Manuel; García Pardo, Marina; Lopez-Campos, Jose Luis; COACH study investigators
A thorough evaluation of the adequacy of clinical practice in a designated health care setting and temporal context is key for clinical care improvement. This study aimed to perform a clinical audit of primary care to evaluate clinical care delivered to patients with COPD in routine clinical practice. The Community Assessment of COPD Health Care (COACH) study was an observational, multicenter, nationwide, non-interventional, retrospective, clinical audit of randomly selected primary care centers in Spain. Two different databases were built: the resources and organization database and the clinical database. From January 1, 2015 to December 31, 2016 consecutive clinical cases of COPD in each participating primary care center (PCC) were audited. For descriptive purposes, we collected data regarding the age at diagnosis of COPD and the age at audit, gender, the setting of the PCC (rural/urban), and comorbidities for each patient. Two guidelines widely and uniformly used in Spain were carefully reviewed to establish a benchmark of adequacy for the audited cases. Clinical performance was analyzed at the patient, center, and regional levels. The degree of adequacy was categorized as excellent (> 80%), good (60-80%), adequate (40-59%), inadequate (20-39%), and highly inadequate ( 80%), good (60-80%), adequate (40-59%), inadequate (20-39%), and highly inadequate ( During the study 4307 cases from 63 primary care centers in 6 regions of the country were audited. Most evaluated parameters were judged to fall in the inadequate performance category. A correct diagnosis based on previous exposure plus spirometric obstruction was made in an average of 17.6% of cases, ranging from 9.8 to 23.3% depending on the region. During the audited visit, only 67 (1.6%) patients had current post-bronchodilator obstructive spirometry; 184 (4.3%) patients had current post-bronchodilator obstructive spirometry during either the audited or initial diagnostic visit. Evaluation of dyspnea was performed in 11.1% of cases. Regarding treatment, 33.6% received no maintenance inhaled therapies (ranging from 31.3% in GOLD A to 7.0% in GOLD D). The two most frequently registered items were exacerbations in the previous year (81.4%) and influenza vaccination (87.7%). The results of this audit revealed a large variability in clinical performance across centers, which was not fully attributable to the severity of the disease.
Erratum to: Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).
(2017-01-12) Rivero-Calle, I; Pardo-Seco, J; Aldaz, P; Vargas, D A; Mascarós, E; Redondo, E; Díaz-Maroto, J L; Linares-Rufo, M; Fierro-Alacio, M J; Gil, A; Molina, J; Ocaña, D; Martinón-Torres, Federico; NEUMOEXPERTOS group
Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).
(2016-11-07) Rivero-Calle, I; Pardo-Seco, J; Aldaz, P; Vargas, D A; Mascarós, E; Redondo, E; Díaz-Maroto, J L; Linares-Rufo, M; Fierro-Alacio, M J; Gil, A; Molina, J; Ocaña, D; Martinón-Torres, Federico; NEUMOEXPERTOS group
Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults even in developed countries. Several lifestyle factors and comorbidities have been linked to an increased risk, although their prevalence has not been well documented in the primary care setting. The aim of this study is to assess the incidence, risk factor and comorbid conditions distribution of CAP in adults in primary care in Spain. Retrospective observational study in adults (>18 years-old) with CAP diagnosed and attended at primary care in Spain between 2009 and 2013, using the Computerized Database for Pharmacoepidemiological Studies in Primary Care (BIFAP). Twenty-eight thousand four hundred thirteen patient records were retrieved and analyzed. Mean age (standard deviation): 60.5 (20.3) years, 51.7 % males. Global incidence of CAP in adults was estimated at 4.63 per 1000 persons/year. CAP incidence increased progressively with age, ranging from a 1.98 at 18-20 years of age to 23.74 in patients over 90 years of age. According to sex, global CAP incidence was slightly higher in males (5.04) than females (4.26); CAP incidence from 18 to 65 year-olds up was comparable between males (range: 2.18-5.75) and females (range: 1.47-5.21), whereas from 65 years of age, CAP incidence was noticeable higher in males (range: 7.06-36.93) than in females (range: 5.43-19.62). Average prevalence of risk factors was 71.3 %, which increased with age, doubling the risk in males by the age of 75 (females 20 % vs males 40 %). From 55 years of age, at least one risk factor was identified in 85.7 % of cases: one risk factor (23.8 %), two risk factors (23.4 %), three or more risk factors (38.5 %). Major risk factors were: metabolic disease (27.4 %), cardiovascular disease (17.8 %) and diabetes (15.5 %). The annual incidence of CAP in primary care adults in Spain is high, comparable between males and females up to 65 years of age, but clearly increasing in males from that age. CAP risk increases with age and doubles in males older than 75 years. The majority of CAP cases in patients over 55 years of age is associated to at least one risk factor. The main risk factors associated were metabolic disease, cardiovascular disease, and diabetes.
Role of the Renin-Angiotensin-Aldosterone System in Dystrophin-Deficient Cardiomyopathy
(MDPI, 2020-12-31) Rodriguez-Gonzalez, Moises; Lubian-Gutierrez, Manuel; Cascales-Poyatos, Helena Maria; Perez-Reviriego, Alvaro Antonio; Castellano-Martinez, Ana; [Rodriguez-Gonzalez,M] Pediatric Cardiology Division of Puerta del Mar University Hospital, University of Cadiz, Cadiz, Spain. [Rodriguez-Gonzalez,M; Castellano-Martinez,A] Biomedical Research and Innovation Institute of Cadiz (INiBICA), Research Unit, Puerta del Mar University Hospital, University of Cadiz, Cadiz, Spain. [Lubian-Gutierrez,M] Pediatric Neurology Division of Puerta del Mar University Hospital, University of Cadiz, Cadiz, Spain. [Lubian-Gutierrez,M] Pediatric Division of Doctor Cayetano Roldan Primary Care Center, San Fernando, Spain. [Cascales-Poyatos,HM; Perez-Reviriego,AA] Pediatric Division of Motril-San Antonio Primary Care Center, Motril, Spain. [Castellano-Martinez,A] Pediatric Nephrology Division of Puerta del Mar University Hospital, University of Cadiz, Cadiz, Spain.
Dystrophin-deficient cardiomyopathy (DDC) is currently the leading cause of death in patients with dystrophinopathies. Targeting myocardial fibrosis (MF) has become a major therapeutic goal in order to prevent the occurrence of DDC. We aimed to review and summarize the current evidence about the role of the renin-angiotensin-aldosterone system (RAAS) in the development and perpetuation of MF in DCC. We conducted a comprehensive search of peer-reviewed English literature on PubMed about this subject. We found increasing preclinical evidence from studies in animal models during the last 20 years pointing out a central role of RAAS in the development of MF in DDC. Local tissue RAAS acts directly mainly through its main fibrotic component angiotensin II (ANG2) and its transducer receptor (AT1R) and downstream TGF-b pathway. Additionally, it modulates the actions of most of the remaining pro-fibrotic factors involved in DDC. Despite limited clinical evidence, RAAS blockade constitutes the most studied, available and promising therapeutic strategy against MF and DDC. Conclusion: Based on the evidence reviewed, it would be recommendable to start RAAS blockade therapy through angiotensin converter enzyme inhibitors (ACEI) or AT1R blockers (ARBs) alone or in combination with mineralocorticoid receptor antagonists (MRa) at the youngest age after the diagnosis of dystrophinopathies, in order to delay the occurrence or slow the progression of MF, even before the detection of any cardiovascular alteration.
Actividad asistencial en Unidades de Salud Bucodental del Servicio Andaluz de Salud durante la desescalada del SARS-CoV-2
(Ministerio de Sanidad, Consumo y Bienestar Social, 2020-06-03) Expósito Delgado, Antonio; Visuerte Sánchez, José Manuel; Soto Ibarreta, María Teresa; Hernández Nieto, Josefina; Cerviño Ferradanes, Santiago; [Expósito Delgado,A] Centro Salud Virgen de Linarejos. Área Gestión Sanitaria Norte de Jaén. Linares (Jaén). España. [Visuerte Sánchez,JM] Unidad Funcional Pacientes con Discapacidad Hospital San Carlos. Distrito Sanitario Bahía de Cádiz La Janda. San Fernando (Cádiz). España. [Soto Ibarreta,MT] Centro Salud Cantillana. Distrito Sanitario Sevilla Norte. Cantillana (Sevilla). España. [Hernández Nieto,J] Centro Periférico de Especialidades Bola Azul. Distrito Sanitario Almería. Almería. España. [Cerviño Ferradanes,S] Centro de Salud La Laguna. Distrito Sanitario Bahía de Cádiz-La Janda. Cádiz. España.
The pandemic declared by SARS-CoV-2 has meant a crisis in the health system that forced the urgent implementation of preventive public health measures. The respiratory transmission virus remains stable on surfaces, being able to spread by air in respiratory droplets or in procedures that generate aerosols. Dental activity is one of the professional sectors with the highest exposure index, both due to the generation of aerosols in most interventions, as well as the impossibility of maintaining a safe distance between patients and professionals. The postponement of scheduled and non-urgent healthcare activities in dental offices is one of the measures implemented to reduce the risk that it posed for the health and well-being of citizens. This report addresses the recommendations and measures to be taken into account to minimize risks in the Oral Health Units of the Andalusian Public Health System, to address the oral pathology of the population assigned in the scenario of improvement of the pandemic and its partial lack of confinement.
Correcting non cephalic presentation with moxibustion: study protocol for a multi-centre randomised controlled trial in general practice.
(BioMed Central, 2008-05-21) Vas, Jorge; Aranda, José Manuel; Barón, Mercedes; Perea-Milla, Emilio; Méndez, Camila; Ramírez, Carmen; Aguilar, Inmaculada; Modesto, Manuela; Lara, Ana María; Martos, Francisco; García-Ruiz, Antonio J; [Vas,J; Aguilar,I; Modesto,M] Pain Treatment Unit, Primary Healthcare Centre, Dos Hermanas, Spain. [Aranda,JM] San Andrés-Torcal Primary Healthcare Centre, Málaga, Spain. [Barón,M] El Lugar Primary Healthcare Centre, Chiclana de la Frontera, Spain. [Perea-Milla,E] Support Research Unit (Network and Cooperative Research Centres of Epidemiology CIBERESP), Costa del Sol Hospital, Marbella, Spain. [Méndez,C] Andalusian Public Health System, Sevilla, Spain. [Ramírez,C] Doña Mercedes Primary Healthcare Centre, Dos Hermanas, Spain. [Lara,AM] Gonzalo Bilbao, Primary Healthcare Centre, Sevilla, Spain. [Martos,F; García-Ruiz,AJ] Department of Pharmacology, Malaga University, Spain.
BACKGROUND Non cephalic presentation in childbirth involves various risks to both the mother and the foetus. The incidence in Spain is 3.8% of all full-term pregnancies. The most common technique used to end the gestation in cases of non cephalic presentation is that of caesarian section, and although it provokes a lower rate of morbi-mortality than does vaginal delivery in such situations, there remains the possibility of traumatic injury to the foetal head and neck, while maternal morbidity is also increased. The application of heat (moxibustion) to an acupuncture point, in order to correct non cephalic presentation, has been practised in China since ancient times, but as yet there is insufficient evidence of its real effectiveness. METHODS/DESIGN The experimental design consists of a multi-centre randomised controlled trial with three parallel arms, used to compare real moxibustion, sham moxibustion and the natural course of events, among pregnant women with a non cephalic presentation and a gestational duration of 33-35 weeks (estimated by echography). The participants in the trial will be blinded to both interventions. The results obtained will be analyzed by professionals, blinded with respect to the allocation to the different types of intervention. In addition, we intend to carry out a economic analysis. DISCUSSION This trial will contribute to the development of evidence concerning moxibustion in the correction of non cephalic presentations. The primary outcome variable is the proportion of cephalic presentations at term. As secondary outcomes, we will evaluate the proportion of cephalic presentations at week 38 of gestation, determined by echography, together with the safety of the technique, the specificity of moxibustion and the control of the blinding process. This study has been funded by the Health Ministry of the Andalusian Regional Government. TRIAL REGISTRATION Current Controlled Trials ISRCTN10634508.
La violencia contra la mujer en la pareja como factor asociado a una mala salud física y psíquica.
(Elsevier, 2004-07) Raya Ortega, L; Ruiz Pérez, I; Plazaola Castaño, J; Brun López-Abisab, S; Rueda Lozano, D; García de Vinuesa, L; González Barranco, J M; Garralon Ruiz, L M; Arnalte Barrera, M; Lahoz Rallo, B; Acemel Hidalgo, M D; Carmona Molina, M P; [Raya,L] Hospital Universitario Virgen de la Victoria. Málaga. España. [Ruiz,I; Plazaola,J] Escuela Andaluza de Salud Pública. Granada. España. [Ruiz,I; Plazaola,J] Red de Investigación Salud y Género. España. [López-Abisab,SB; Lahoz,B] Unidad Docente de MFyC. Cádiz. España. [Rueda,D; Carmona,MP] Centro de Salud La Chana. Granada. España. [García,L] Centro de Salud La Carlota. Córdoba. España. [González,JM] Centro de Salud de la Fuensanta. Córdoba. España. [Garralon,LM] Centro de Salud de Puerto Real. Cádiz. España. [Arnalte,M] Centro de Salud de la Merced. Cádiz. España. [Acemel,MD] Centro de Salud de San Telmo. Cádiz. España.; Fuente de financiación: Red Temática de Investigación de Salud y Género (ISCIII) (G03/042) y Red de Investigación en Epidemiología y Salud Pública (C03/09).
OBJECTIVE: To study the impact of intimate partner violence (IPV) on women's physical and psychological health. DESIGN: Cross-sectional study. SETTING:Primary care centers in 3 Andalusian provinces. PATIENTS: A total of 425 women, aged 18 to 65 years, were recruited following the same randomisation process in 6 primary care centers. MEASUREMENTS: A self-administered structured questionnaire for this study was used to gather the information. As well as sociodemographic variables, the instrument included questions about IPV, physical health indicators (chronic disease and type, lifetime surgeries, days in bed), psychological health (psychological morbidity, use of tranquilizers, antidepressants, pain killers, alcohol and recreational drugs), self-perceived health and social support. RESULTS: Of 425 women, 31.5% ever experienced any type of partner violence. Women experiencing IPV were more likely to suffer a chronic disease. IPV was significantly associated with a number of adverse health outcomes, including spending more than 7 days in bed in the last three months (ORa=2.96; CI 95%, 1.00-8.76), psychological morbidity (ORa=2.68; CI 95%, 1.60-4.49) and worse self-perceived health (ORa=1.89; CI 95%, 1.04-3.43), after controlling for potential confounding variables. CONCLUSION: This study shows that ever experiencing IPV is associated with a worse psychological and self-perceived health. Physical injuries are not the only "evidence" of the presence of IPV. Primary health care professionals are in a privileged position to help women who are abused by their partners.
Quiste dentígero asociado con mesiodens: Exposición de un caso, revisión de la literatura y diagnóstico diferencial.
(Ediciones Avances Médico Dentales, S.L., 2011-11) Rodríguez Romero, FJ; Cerviño Ferradanes, S; Muriel Cueto, P; [Rodriguez Romero, FJ; Cerviño Ferradanes, S] U.G.C. de Salud Bucodental, Distrito de Atención Primaria “Cádiz-La Janda”, Centro de Salud “La Laguna” Cádiz. [Muriel Cueto, P] Servicio de Anatomía Patológica , Hospital Universitario Puerta del Mar”, Cádiz
Dentigerous cyst is one of the most prevalent types of odontogenic cyst and is associated with crown of an unerupted or developing tooth. Dentigerous cysts associated with supernumerary teeth are rare and estimated to constitute 5-6% of all dentigerous cysts. The vast majority, about 90%, are associated with a maxillary mesiodens. The purpose of this article to report the case of an 14-year-old a teenager with a dentigerous cyst associated with an impacted anterior maxillary supernumerary tooth, its dental management and literature review.

Browse

Recent Submissions